A recent study conducted by researchers at New York University revealed that weight-loss surgeries, such as gastric sleeve and bypass, clearly outperform “Ozempic” and other semaglutide drugs, proving more than five times as effective over two years, which raises questions about the long-term effectiveness of pharmacological treatments.
Clear Difference in Results
According to a report published by “Science Alert” on Wednesday, the study was based on a review of health records for a group of patients who underwent bariatric surgery and others who took GLP-1 medications like semaglutide. The results showed that the surgery group lost about 25.7% of their body weight within two years, compared to only 5.3% in the medication group.
Commitment as a Decisive Factor
Researchers attributed this difference to poor patient adherence to taking the medications over the long term. Avery Brown, from the Department of Surgery at NYU, said: “Clinical trials show weight loss ranging between 15 and 21%, but reality is different… as many as 70% of patients may stop taking the medication within a year.”
Strong Results, but Surgery Remains a Limited Option
Despite the confirmation of surgery’s effectiveness, the study was funded by the American Society for Metabolic and Bariatric Surgery (ASMBS), which may indicate a potential conflict of interest. Anne Rogers, president of the society, said: “Metabolic and bariatric surgery is more effective and sustainable than pharmacological treatments.”
Bariatric surgeries remain a less widespread option despite their superior results, while drugs like “Ozempic” maintain their position in treating diabetes and reducing the risks of heart disease.
United News Network – UNN Arabic
An independent media platform providing reliable news and objective analysis, seeking to promote peace and cultural dialogue around the world to convey the truth and build bridges of understanding between peoples.
For more news, you can visit our homepage:
